January 2022
Financial Advisor (Sell side)
Joint Bookrunner (CMPO)
Financial Advisor to Neuronetics on its Merger with Greenbrook TMS
Advisor to UCB on the Sale of the Rights of Nootropil® and Atarax® Products to Advanz Pharma
